Cmi: Difference between revisions

From Proteopedia
Jump to navigationJump to search
New page: Cmi is the Colicin Immunity Protein produced by ''E. coli'' against the cytotoxic domain of Colicin M that inhibits peptidoglycan synthesis. Once the complex has bound to an outer ...
 
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{STRUCTURE_2xgl |  PDB=2xgl  |  SCENE= Cmi/Cmidimer/1 }}
Cmi is the [[Colicin Immunity Protein]] produced by ''E. coli'' against the cytotoxic domain of [[Colicin M]] that inhibits peptidoglycan synthesis. Once the complex has bound to an outer membrane receptor of a target cell the immunity protein is released from the [[Colicin]].
Cmi is the [[Colicin Immunity Protein]] produced by ''E. coli'' against the cytotoxic domain of [[Colicin M]] that inhibits peptidoglycan synthesis. Once the complex has bound to an outer membrane receptor of a target cell the immunity protein is released from the [[Colicin]].
<scene name='Cmi/Cmimono/1'>Monomer</scene> of Cmi.

Latest revision as of 15:01, 25 February 2011

Drag the structure with the mouse to rotate
2xgl, resolution 2.70Å (default scene)
Ligands: CD, CL, NA


Resources: FirstGlance, OCA, PDBsum, RCSB
Coordinates: save as pdb, mmCIF, xml


Cmi is the Colicin Immunity Protein produced by E. coli against the cytotoxic domain of Colicin M that inhibits peptidoglycan synthesis. Once the complex has bound to an outer membrane receptor of a target cell the immunity protein is released from the Colicin.

Monomer of Cmi.

Proteopedia Page Contributors and Editors (what is this?)

Gemma McGoldrick